Pharma & Biotech

Investors in Catalyst Pharmaceuticals are bracing for a significant market-moving event this week as the biopharma company prepares to release...

This week represents a critical juncture for Altimmune as the biopharmaceutical company prepares to release its third-quarter 2025 financial results...

The German biotech firm CureVac has delivered a remarkable financial performance that has captivated both investors and market analysts. After...

BioNxt Solutions, a Canadian life sciences company, has reached a significant regulatory milestone that could strengthen its intellectual property portfolio....

Biotechnology firm Ocugen stands at a pivotal juncture as it prepares to release third-quarter financial results on Wednesday, November 5....

Investors in Viking Therapeutics were met with sobering financial results for the third quarter of 2025, as the biotechnology firm...

Eli Lilly delivered a stunning financial performance that exceeded even the most optimistic market forecasts when it released quarterly results...

Glaukos Corporation has ignited investor enthusiasm with a powerful trifecta of developments, propelling its stock to impressive gains. The equity...

All eyes are on Vericel as the biopharmaceutical company prepares to release its quarterly financial results this Thursday. Market expectations...

Pulmonx Corp witnessed a dramatic single-day rally, with its stock price soaring more than 26% following significant corporate developments. The...